Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 109.74 -2.27 (-2.03%) Market Cap: 6.92 Bil Enterprise Value: 11.03 Bil PE Ratio: 22.63 PB Ratio: 1.87 GF Score: 78/100

Jazz Pharmaceuticals PLC at Evercore ISI HealthCONx Virtual Conference Transcript

Nov 30, 2021 / 07:40PM GMT
Release Date Price: $119.87 (-2.07%)
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Thank you, guys, for joining us. It's a pleasure to have Jazz management along with their new CEO with the shaved look, Bruce Cozadd, joining us. Bruce, thank you, guys, for being here.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

Yes. Umer, really great to be here. And maybe before we hit Q&A, I'll just make a couple of opening remarks. For those of you who haven't seen me without a beard before, it is true that, while everyone else grew COVID beard, I lost a COVID beard, and so I'm beardless for the first time in 29 years.

Before I start my official comments, I'll just point out we will make forward-looking statements today, and those are, of course, subject to risk factors you can read about in our SEC filings. I'll probably also refer to non-GAAP financial measures. See our website for a full reconciliation. And if and when I refer to guidance, I'm not updating. I'm referring to guidance we gave

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot